Can fecal microbiota transplantation cure irritable bowel syndrome?

World Journal of Gastroenterology

Volumn 23, Issue 22, 2017, Pages 4112-4120

  Halkjær, Sofie Ingdam ^a,b   Boolsen, Anders Watt ^c   Günther, Stig ^b   Christensen, Alice Højer ^b   Petersen, Andreas Munk ^a,c,d  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Hamlet Private Hospital   (Denmark)

^c Mental Health Center Glostrup   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Fecal microbiota transplantation; Irritable bowel syndrome; Microbiota

Indexed keywords

ABDOMINAL PAIN; BLOATING; CHRONIC CONSTIPATION; CLINICAL EFFECTIVENESS; DEFECATION HABIT; DYSPEPSIA; FECAL MICROBIOTA TRANSPLANTATION; FLATULENCE; HUMAN; IRRITABLE COLON; OUTCOME ASSESSMENT; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; FECES; INTESTINE; MICROBIOLOGY; REMISSION; TREATMENT OUTCOME;

FECAL MICROBIOTA TRANSPLANTATION; FECES; HUMANS; INTESTINES; IRRITABLE BOWEL SYNDROME; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 85020487726     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v23.i22.4112     Document Type: Review

References (42)

1. Rossen NG, MacDonald JK, de Vries EM, D'Haens GR, de Vos WM, Zoetendal EG, Ponsioen CY. Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review. World J Gastroenterol 2015; 21: 5359-5371 [PMID: 25954111 DOI: 10.3748/wjg.v21.i17.5359]
2. Khanna S, Tosh PK. A clinician's primer on the role of the microbiome in human health and disease. Mayo Clin Proc 2014; 89: 107-114 [PMID: 24388028 DOI: 10.1016/ j.mayocp.2013.10.011]
3. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33 [PMID: 17631127 DOI: 10.1053/j.gastro.2007.04.005]
4. King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998; 352: 1187-1189 [PMID: 9777836]
5. Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100: 373-382 [PMID: 15667495 DOI: 10.1111/j.1572-0241.2005.40312.x]
6. Mättö J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005; 43: 213-222 [PMID: 15747442]
7. Singh R, Nieuwdorp M, ten Berge IJ, Bemelman FJ, Geerlings SE. The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection. Clin Microbiol Infect 2014; 20: 1119-1125 [PMID: 25274035 DOI: 10.1111/1469-0691.12799]
8. Kang DW, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A, Khoruts A, Geis E, Maldonado J, McDonough-Means S, Pollard EL, Roux S, Sadowsky MJ, Lipson KS, Sullivan MB, Caporaso JG, Krajmalnik-Brown R. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome 2017; 5: 10 [PMID: 28122648 DOI: 10.1186/s40168-016-0225-7]
9. Dinan TG, Cryan JF. Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil 2013; 25: 713-719 [PMID: 23910373 DOI: 10.1111/nmo.12198]
10. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-721.e4 [PMID: 22426087 DOI: 10.1016/ j.cgh.2012.02.029]
11. Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep 2009; 11: 265-269 [PMID: 19615301]
12. Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014; 40: 1023-1034 [PMID: 25199904 DOI: 10.1111/apt.12938]
13. Tap J, Derrien M, Törnblom H, Brazeilles R, Cools-Portier S, Doré J, Störsrud S, Le Nevé B, Öhman L, Simrén M. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. Gastroenterology 2017; 152: 111-123. e8 [PMID: 27725146 DOI: 10.1053/j.gastro.2016.09.049]
14. Pinn DM, Aroniadis OC, Brandt LJ. Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)? Neurogastroenterol Motil 2015; 27: 19-29 [PMID: 25424663 DOI: 10.1111/ nmo.12479]
15. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-1988 [PMID: 19457422 DOI: 10.1053/j.gastro.2009.02.074]
16. Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, Moore T, Wu G. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology 2015; 149: 223-237 [PMID: 25982290 DOI: 10.1053/j.gastro.2015.05.008]
17. Choi HH, Cho YS. Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives. Clin Endosc 2016; 49: 257-265 [PMID: 26956193 DOI: 10.5946/ce.2015.117]
18. Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol 2014; 20: 6759-6773 [PMID: 24944467 DOI: 10.3748/wjg.v20. i22.6759]
19. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491 [PMID: 16678561 DOI: 10.1053/ j.gastro.2005.11.061]
20. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA 2015; 313: 949-958 [PMID: 25734736 DOI: 10.1001/jama.2015.0954]
21. Hungin AP, Mulligan C, Pot B, Whorwell P, Agréus L, Fracasso P, Lionis C, Mendive J, Philippart de Foy JM, Rubin G, Winchester C, de Wit N. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidencebased international guide. Aliment Pharmacol Ther 2013; 38: 864-886 [PMID: 23981066 DOI: 10.1111/apt.12460]
22. Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol 2015; 21: 3072-3084 [PMID: 25780308 DOI: 10.3748/wjg.v21.i10.3072]
23. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr 2001; 73: 399S-405S [PMID: 11157348]
24. Hayes PA, Fraher MH, Quigley EM. Irritable bowel syndrome: the role of food in pathogenesis and management. Gastroenterol Hepatol (N Y) 2014; 10: 164-174 [PMID: 24829543]
25. Shah SL, Lacy BE. Dietary Interventions and Irritable Bowel Syndrome: A Review of the Evidence. Curr Gastroenterol Rep 2016; 18: 41 [PMID: 27372289 DOI: 10.1007/s11894-016-0517-x]
26. Borody T, McGrath K. Treatment of chronic constipation and colitis using human probiotic infusions. Rome: Probiotics, Prebiotics and New Foods Conference, Universita Urbaniana, 2001
27. Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S. Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol 2004; 38: 475-483 [PMID: 15220681]
28. Pinn D, Aroniadis O, Brandt L. Follow-up study of fecal microbiota transplantation (FMT) for the treatment of refractory irritable bowel syndrome (IBS). Am J Gastroenterol 2013; 108: S563
29. Holvoet T, Boelens J, Joossens M, Raes J, Vos MD, Looze DD. Tu2025 Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating: Results From a Prospective Pilot Study. Gastroenterology 2015; 148: S-963-S-964 [DOI: 10.1016/ S0016-5085(15)33291-1]
30. Cruz Aguilar R, Buch T, Bajbouj. Fecal microbiota transplantation as a novel therapy for irritable bowel syndrome with predominant diarrhea. Neurogastroenterol Motil 2015; 27 (Suppl 2): 110
31. Hong J, Bang B, Shin Y, Kim H, Kwon K. OP257 Treatment of Irritable Bowel Syndrome with Fecal Microbiota Transplantation: A case series of 10 patients. Unit Eur Gastroenterol J 2016; 2 (Suppl 1)
32. Syzenko G, Budovska L, Puchkov K. P0397 Efficiency of FMT in cases of 'Treatment-resistant' IBS. Unit Eur Gastroenterol J 2016; 2 (Suppl 1)
33. Mazzawi T, Lied G, El-Salhy M, Gilja O, Hatlebakk J, Hausken T. P1527 Effect of faecal microbiota transplantation on symptoms and duodenal enteroendocrine cells in patients with irritable bowel syndrome. Unit Eur Gastroenterol J 2016; 2 (Suppl 1)
34. Andrews P, Barnes P, Borody T. Chronic constipation reversed by restoration of bowel flora - a case and a hypothesis. Eur J Gastroenterol Hepatol 1992; 4: 245-7
35. Borody TJ, George L, Andrews P, Brandl S, Noonan S, Cole P, Hyland L, Morgan A, Maysey J, Moore-Jones D. Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989; 150: 604 [PMID: 2783214]
36. Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep 2013; 15: 337 [PMID: 23852569 DOI: 10.1007/s11894-013-0337-1]
37. Pinn DM, Aroniadis OC, Brandt LJ. Is fecal microbiota transplantation the answer for irritable bowel syndrome? A singlecenter experience. Am J Gastroenterol 2014; 109: 1831-1832 [PMID: 25373585 DOI: 10.1038/ajg.2014.295]
38. Holvoet T, Joossens M, Wang J, Boelens J, Verhasselt B, Laukens D, van Vlierberghe H, Hindryckx P, De Vos M, De Looze D, Raes J. Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating. Gut 2017; 66: 980-982 [PMID: 27511198 DOI: 10.1136/gutjnl-2016-312513]
39. Menees SB, Maneerattannaporn M, Kim HM, Chey WD. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol 2012; 107: 28-35; quiz 36 [PMID: 22045120 DOI: 10.1038/ajg.2011.355]
40. Patel SM, Stason WB, Legedza A, Ock SM, Kaptchuk TJ, Conboy L, Canenguez K, Park JK, Kelly E, Jacobson E, Kerr CE, Lembo AJ. The placebo effect in irritable bowel syndrome trials: a metaanalysis. Neurogastroenterol Motil 2005; 17: 332-340 [PMID: 15916620 DOI: 10.1111/j.1365-2982.2005.00650.x]
41. Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, Yan F, Cao H, Wang B. Systematic Review: Adverse Events of Fecal Microbiota Transplantation. PLoS One 2016; 11: e0161174 [PMID: 27529553 DOI: 10.1371/journal.pone.0161174]
42. Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, Sokol H, Arkkila P, Pintus C, Hart A, Segal J, Aloi M, Masucci L, Molinaro A, Scaldaferri F, Gasbarrini G, Lopez-Sanroman A, Link A, de Groot P, de Vos WM, Högenauer C, Malfertheiner P, Mattila E, Milosavljević T, Nieuwdorp M, Sanguinetti M, Simren M, Gasbarrini A. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017; 66: 569-580 [PMID: 28087657 DOI: 10.1136/ gutjnl-2016-313017]